Long-acting injectable drug prevents HIV infections

May 20, 2020

A long-acting antiretroviral drug given as an injection every 2 months powerfully protected uninfected people from HIV in a large-scale study. The study has not been published in a peer-reviewed journal or presented to HIV researchers at a meeting The apparent success offers a potentially easier alternative to taking daily pills of other antiretrovirals, which has proved difficult for many people. Science


Other news